• Issue

    Cancer Communications: Volume 44, Issue 9

    927-1097
    September 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 927-928
  • First Published: 23 September 2024

REVIEW

Open Access

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment

Fusheng Zhang,  Junchen Guo,  Shengmiao Yu,  Youwei Zheng,  Meiqi Duan,  Liang Zhao,  Yihan Wang,  Zhi Yang,  Xiaofeng Jiang, 
  • Pages: 929-966
  • First Published: 12 July 2024
Open Access

Immune mediated support of metastasis: Implication for bone invasion

Zengfeng Xin,  Luying Qin,  Yang Tang,  Siyu Guo,  Fangfang Li,  Yuan Fang,  Gege Li,  Yihan Yao,  Binbin Zheng,  Bicheng Zhang,  Dang Wu,  Jie Xiao,  Chao Ni,  Qichun Wei,  Ting Zhang, 
  • Pages: 967-991
  • First Published: 14 July 2024

ORIGINAL ARTICLE

Open Access

Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study

Lin Li,  Wencai Li,  Chunyan Wu,  Yanfeng Xi,  Lei Guo,  Yuan Ji,  Lili Jiang,  Ji Li,  Jingping Yun,  Gang Chen,  Yuan Li,  Yueping Liu,  Dianbin Mu,  Yuchen Han,  Leina Sun,  Qingxin Xia,  Xiaodong Teng,  Nanying Che,  Wei Wu,  Xueshan Qiu,  Chao Liu,  Xiaochu Yan,  Daiqiang Li,  Zhihong Zhang,  Zhe Wang,  Yujun Li,  Zheng Wang,  Lingchuan Guo,  Xiu Nie,  Jingshu Geng,  Jianhua Zhou,  Jianming Ying, 
  • Pages: 992-1004
  • First Published: 17 July 2024
Open Access

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)

Shun Lu,  Xiaorong Dong,  Hong Jian,  Jianhua Chen,  Gongyan Chen,  Yuping Sun,  Yinghua Ji,  Ziping Wang,  Jianhua Shi,  Junguo Lu,  Shaoshui Chen,  Dongqing Lv,  Guojun Zhang,  Chunling Liu,  Juan Li,  Xinmin Yu,  Zhong Lin,  Zhuang Yu,  Zhehai Wang,  Jiuwei Cui,  Xingxiang Xu,  Jian Fang,  Jifeng Feng,  Zhi Xu,  Rui Ma,  Jie Hu,  Nong Yang,  Xiangdong Zhou,  Xiaohong Wu,  Chengping Hu,  Zhihong Zhang,  You Lu,  Yanping Hu,  Liyan Jiang,  Qiming wang,  Renhua Guo,  Jianying Zhou,  Baolan Li,  Chunhong Hu,  Wancheng Tong,  Helong Zhang,  Lin Ma,  Yuan Chen,  Zhijun Jie,  Yu Yao,  Longzhen Zhang,  Jie Weng,  Weidong Li,  Jianping Xiong,  Xianwei Ye,  Jianchun Duan,  Haihua Yang,  Meili Sun,  Hongying Wei,  Jiawei Wei,  Zheyu Zhang,  Qiong Wu, 
  • Pages: 1005-1017
  • First Published: 17 July 2024
Open Access

Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation

Hailing Liu,  Lei Xu,  Shiwei Yue,  Hongfei Su,  Xing Chen,  Qiumeng Liu,  Hui Li,  Huifang Liang,  Xiaoping Chen,  Jiefeng He,  Zeyang Ding,  Bixiang Zhang, 
  • Pages: 1018-1041
  • First Published: 19 July 2024

LETTER TO THE JOURNAL

Open Access

Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial

Jing Zuo,  Wei Duan,  Mingxuan Zhao,  Zhendong Chen,  Jie Lin,  Huaqiu Shi,  Ou Jiang,  Youzhong Zhang,  Meiyu Fang,  Li Wang,  Wei Wang,  Yong Huang,  Junyan Yu,  Xiaoxue Zhang,  Weiqing Pu,  Deshun Hao,  Fenglin She,  Xiugao Yang,  Ying Chen,  Qizhi Tang,  Xiao Zhang,  Miao Niu,  Yan'e Song,  Lingying Wu, 
  • Pages: 1042-1046
  • First Published: 23 July 2024

REVIEW

Open Access

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy

Jie Chen,  Yuhang Duan,  Junye Che,  Jianwei Zhu, 
  • Pages: 1047-1070
  • First Published: 25 July 2024
Open Access

Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies

Wenyue Sun,  Shunfeng Hu,  Xin Wang, 
  • Pages: 1071-1097
  • First Published: 28 July 2024